Aevi Genomic Medicine, Inc.
Aevi Genomic Medicine, Inc. (GNMX) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 43 transactions totaling $9.3M, demonstrating a bullish sentiment with $8.2M in net insider flow. The most recent transaction on Feb 3, 2020 involved a transaction of 2,164,150 shares valued at $0.
GNMX Insider Activity Summary
Who Is Buying GNMX Stock?
No significant insider buying has been recorded for GNMX in the recent period.
Who Is Selling GNMX Stock?
No significant insider selling has been recorded for GNMX in the recent period.
Is Aevi Genomic Medicine, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for GNMX is bullish with an Insider Alignment Score of 94/100 and a net flow of $8.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
GNMX Frequently Asked Questions
Understanding GNMX Insider Activity
Insider trading at Aevi Genomic Medicine, Inc. (GNMX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading GNMX stock, having executed 43 transactions in the past 90 days. The most active insider is Sol J. Barer (Executive), who has made 11 transactions totaling $3.8M.
Related Tools
Track Aevi Genomic Medicine, Inc. Insider Activity
Get notified when executives and directors at GNMX file new Form 4 transactions